Genetic Technologies Ltd (GENE) — Capital Reinvestment Ratio
Latest as of June 2011:
0.06x
Genetic Technologies Ltd (GENE) has a Capital Reinvestment Ratio of 0.06x as of June 2011, meaning it reinvests 0% of its operating cash flow ($1.12 Million) in capital expenditures ($69.84K). See cash generation quality of Genetic Technologies Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
$1.12 Million
USD
Capital Expenditures
$69.84K
USD
Data as of
Jun 2011
Most recent filing
Genetic Technologies Ltd Capital Reinvestment Ratio (2007–2011)
This chart tracks Genetic Technologies Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Genetic Technologies Ltd (2007–2011)
Year-by-year Capital Reinvestment Ratio for Genetic Technologies Ltd from 2007 to 2011. For live market cap and broader valuation context, see market value of Genetic Technologies Ltd.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.06x | $2.23 Million | $139.68K | ▼ -77.6% |
| 2008 | 0.28x | $423.68K | $118.26K | ▲ +286.6% |
| 2007 | 0.07x | $2.20 Million | $158.87K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow